CHRS Net Margin
-257.10%TTM
Period ending:
CHRS FY Net Margin%
1867.91%-17146.68%
2012-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
CHRS net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| -403.8011% | |
| 10.6784% | |
| -92.4772% | |
| -138.2445% | |
| -87.9189% | |
| 27.7926% | |
| 25.229% | |
| -13,453.6632% | |
| -15,306.5553% | |
| -66.9821% | |
| -743.1843% | |
| -280.1164% | |
| -1,949.6547% | |
| -1,738.7046% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All CHRS financial metrics · CHRS stock overview · How to interpret financial metrics
